|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 24, 2016 ) Algeria Pharmaceuticals & Healthcare Report
We remain optimistic about Algeria 's longer term potential as a pharmaceutical market, underpinned by economic and demographic factors. Our view is supported by a number of investments into the local manufacturing sector made by foreign players in recent months, in partnerships with local companies. However, the country does pose numerous operational risks, which will continue to hamper the development of its full potential until the deficiencies are successfully addressed.
Headline Expenditure Projections:
Pharmaceuticals: DZD218.52bn (US$3.00bn) in 2011 to DZD239.44bn (US$3.19bn) in 2012; +9.6% in local currency terms and +6.5% in US dollar terms. Forecast unchanged from Q4 12.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=206952
Healthcare: DZD530.66bn (US$7.28bn) in 2011 to DZD585.52bn (US$7.81bn) in 2012; +10.3% in local currency terms and +7.2% in US dollar terms. Forecast unchanged from Q4 12.
Medical Devices: DZD28.26bn (US$388mn) in 2011 to DZD30.83bn (US$411mn) in 2012; +9.1% in local currency terms and +6.0% in US dollar terms. Forecast unchanged from Q4 12.
Risk/Reward Rating
In Q1 12, Algeria retains its composite score of 46.6 out of the maximum 100 points and also its place as the 14th most attractive Middle East and Africa (MEA) pharmaceutical market, out of the 30 countries surveyed within the region. Despite above-average rewards opportunities, Algeria continues to be viewed as a very risky market, both on the industry and the country side, with this quarter's score for overall risks remaining at just 34 out of 100.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Browse Detail Report With TOC @ http://www.researchmoz.us/the-pharmaceutical-market-algeria-report.html
Table of Contents
Executive Summary 5
SWOT Analysis 7
Algeria Pharmaceuticals And Healthcare Industry SWOT 7
Algeria Political SWOT 8
Algeria Economic SWOT 8
Algeria Business Environment SWOT 8
Pharmaceutical Risk/Reward Ratings 10
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=206952
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
